Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1534676
Name of medicinal product: BLASTOMAT 100 MG
Active substances:
Temozolomide
Estonian, English, Latin
ATC code: L01AX03
Dosage form: capsule, hard
Route of administration: oral use
Strengh: 100mg
Amount in package: 5TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: is indicated for the treatment of: - Adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. - Children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Safety features: Yes
Summary of product characteristics (SPC):  (last updated April 29, 2021)
Package information leaflet (PIL): EST  (last updated April 29, 2021)
Labelling:  (last updated September 12, 2018)
Last imported to Estonia: April 17, 2024
Marketing authorization holder: Zentiva k.s. 
Marketing authorization number: 799612 
Marketing authorization issued on: October 29, 2012 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
100  05.04.2024     Yes  C71-C71  Onkoloog, Pediaater – hematoloog-onkoloog  No     konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) 
100  05.04.2024     Yes  C71-C71  Onkoloog, Pediaater – hematoloog-onkoloog  No  until 4 years  konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) 
50  05.04.2024     Yes      No      
100  05.04.2024     Yes      No  until 4 years   
Reference price: 93,20 EUR 
Under reference price: No 
Reference price of daily dose: 13,98 EUR 
Entry/Changing date: March 7, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere